Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2016-01-22 Regulatory Filings
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Exercise of Share Options
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains an announcement dated January 22, 2016, from Alliance Pharma PLC. The core content announces the 'Exercise of Share Options' and the subsequent application for admission to trading of 63,620 new Ordinary Shares. This action directly relates to changes in the company's share capital structure due to employee option exercises. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers announcements regarding new share issues or capital changes. Although it is distributed via RNS, the specific nature of the announcement points more precisely to SHA than the general fallback RNS code.
2016-01-22 English
Pre-Close Trading Update
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content is a 'Pre-Close Trading Update' for the year ended 31 December 2015, providing preliminary revenue and profit expectations ahead of the official preliminary results announcement scheduled for April 7, 2016. This type of announcement, which provides key financial highlights before the full report, aligns best with an Earnings Release (ER). Although it is distributed via RNS, the primary function is to release earnings expectations, not just general news. FY 2015
2016-01-21 English
Notification of Major Interest in Shares
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6283L' and the footer 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' filed by 'River and Mercantile Asset Management LLP' regarding a change in their holding percentage (crossing the 5% threshold) in Alliance Pharma PLC. This type of filing, reporting changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is an RNS announcement, MRQ is a more specific classification than the general RNS fallback.
2016-01-12 English
Notification of Major Interest in Shares
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 1796L' and contains a standardized form titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES'. This form is used to report changes in significant shareholdings, which directly corresponds to the definition of a Major Shareholding Notification. The content details the shareholder (FMR LLC), the date the threshold was crossed (5th January 2016), and the resulting percentage of voting rights (6.12%). This fits the 'Major Shareholding Notification' category (MRQ) better than the general 'Regulatory Filings' (RNS) because MRQ is a specific type of regulatory disclosure.
2016-01-07 English
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 0500K' and the footer 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', which reports changes in significant share ownership (crossing the 11% threshold) by a shareholder (MVM LIFE SCIENCE PARTNERS LLP) in Alliance Pharma PLC. This type of filing, reporting changes in major shareholdings, corresponds directly to the Major Shareholding Notification category (MRQ). Although it is an RNS release, MRQ is the more specific classification for the content type.
2015-12-23 English
Notification of Major Interest in Shares
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly labeled with "RNS Number : 6443J" and contains the header "TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES". This format is characteristic of regulatory notifications concerning changes in significant shareholdings, which falls under the category of Major Shareholding Notification (MRQ). Although RNS is present, MRQ is a more specific classification for this type of filing content (change in ownership threshold/voting rights). The content details the change in voting rights percentage for Aviva plc, confirming it is a major shareholder notification.
2015-12-18 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.